BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/28/2017 6:54:48 AM | Browse: 603 | Download: 748
Publication Name World Journal of Gastroenterology
Manuscript ID 34887
Country/Territory China
2017-05-31 01:43
Peer-Review Started
2017-05-31 01:53
To Make the First Decision
2017-06-22 02:39
Return for Revision
2017-06-22 05:29
2017-07-03 05:12
Second Decision
2017-07-06 11:35
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2017-07-12 04:14
Articles in Press
2017-07-12 04:14
Publication Fee Transferred
2017-07-20 06:06
Edit the Manuscript by Language Editor
2017-07-27 10:13
Typeset the Manuscript
2017-08-18 07:13
Publish the Manuscript Online
2017-08-28 06:54
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology and Hepatology
Manuscript Type Prospective Study
Article Title Efficacy and safety of sofosbuvir and daclatasvir in treatment of kidney transplantation recipients with hepatitis C virus infection
Manuscript Source Unsolicited Manuscript
All Author List Yan Xue, Li-Xin Zhang, Lei Wang, Tao Li, Yun-Dong Qu and Feng Liu
Author(s) ORCID Number
Yan Xue http://orcid.org/0000-0001-6185-2424
Li-Xin Zhang http://orcid.org/0000-0001-9795-6487
Lei Wang http://orcid.org/0000-0002-8240-9795
Tao Li http://orcid.org/0000-0002-2548-5476
Yun-Dong Qu http://orcid.org/0000-0003-4119-4422
Feng Liu http://orcid.org/0000-0001-7060-3710
Funding Agency and Grant Number
Funding Agency Grant Number
Project of Science and Technology Development Plan of Ji'nan city 201506004
Youth Fund of 2nd Hospital of Shandong University Y2014010014
Corresponding author Lei Wang, MD, PhD, Professor, Department of Infectious Diseases and Hepatology, the Second Hospital of Shandong University, 247 Beiyuan Road, Jinan 250033, Shandong Province, China. wlcrb@sdu.edu.cn
Keywords Hepatitis C virus; Sofosbuvir; Daclatasvir; Kidney transplantation; Direct-acting antivirals
Core Tip This is a prospective study to assess the efficacy and safety of sofosbuvir and daclatasvir regimens for kidney transplantation (KT) patients with hepatitis C virus (HCV) infection. This study enrolled a prospective cohort of consecutive Chinese KT patients with HCV infection. The recipients were given sofosbuvir combined with daclatasvir with or without ribavirin. Sofosbuvir and daclatasvir treatments are highly efficient and safe. Patients tolerated the regimens and no serious adverse events were observed. Larger prospective cohort studies are needed to validate these results.
Publish Date 2017-08-28 06:54
Citation Xue Y, Zhang LX, Wang L, Li T, Qu YD, Liu F. Efficacy and safety of sofosbuvir and daclatasvir in treatment of kidney transplantation recipients with hepatitis C virus infection. World J Gastroenterol 2017; 23(32): 5969-5976
Url http://www.wjgnet.com/1007-9327/full/v23/i32/5969.htm
DOI http://dx.doi.org/10.3748/wjg.v23.i32.5969
Full Article (PDF) WJG-23-5969.pdf
Full Article (Word) WJG-23-5969.doc
Manuscript File 34887-Review.doc
Answering Reviewers 34887-Answering reviewers.pdf
Audio Core Tip 34887-Audio core tip.mp3
Biostatistics Review Certificate 34887-Biostatistics statement.pdf
Clinical Trial Registration Statement 34887-Clinical trial registration statement.pdf
Conflict-of-Interest Disclosure Form 34887-Conflict-of-interest statement.pdf
Copyright License Agreement 34887-Copyright assignment.pdf
Data Sharing Statement 34887-Data sharing statement.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s) 34887-Grant Application Form(s).pdf
Signed Informed Consent Form(s) or Document(s) 34887-Informed consent statement.pdf
Institutional Review Board Approval Form or Document 34887-Institutional review board statement.pdf
Non-Native Speakers of English Editing Certificate 34887-Language certificate.pdf
Scientific Research Process 34887-Scientific research process.pdf
Peer-review Report 34887-Peer-review(s).pdf
Scientific Misconduct Check 34887-Scientific misconduct check.pdf
Scientific Editor Work List 34887-Scientific editor work list.pdf